Horizon Pharma plc to Participate in Two Conferences in June
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Leerink Partners Starts Horizon Pharma (HZNP) at Outperform
May 22, 2015 7:00 AM EDTLeerink Partners initiates coverage on Horizon Pharma (NASDAQ: HZNP) with a Outperform rating and a price target of $37.00.
Analyst Jason Gerberry commented, "We are initiating coverage of HZNP with an Outperform rating based on: (1) under-appreciated durability of legacy primary care brands while... More
